Pain, Body Composition and Physical Activity in Childhood Cancer.
Exploring Pain, Body Composition and Physical Activity in Childhood Cancer: a Case Control Study
1 other identifier
observational
60
1 country
1
Brief Summary
Comparing baseline assessments of children with cancer and their parents with baseline assessments of healthy children and their parents in a case-control study will allow the investigators to make the comparison in terms of pressure hyperalgesia, pain catastrophizing, energy-balance related behavior, attention control and attention bias between healthy children and cancer patients. This also enables the investigators to compare parents of healthy children with parents of cancer patients in the field of catastrophizing about the pain of their child and responses to child's pain experiences. Correlations can also be calculated between, for example, pain pressure thresholds and energy-balance related behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2019
CompletedFirst Posted
Study publicly available on registry
July 2, 2019
CompletedStudy Start
First participant enrolled
August 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2022
CompletedJune 15, 2022
June 1, 2022
2.8 years
June 19, 2019
June 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure hyperalgesia (child)
Pain response to stimuli that are normally not painful, induced by the lowering of the nociceptor threshold level and assessed by evaluating pressure pain thresholds (PPTs) at the dominant tibialis anterior and trapezius muscle by means of a digital pressure algometer (FPX 50, Wagner Instruments, Greenwich, CT, USA). Per test site, 3 measurements are performed with 30 seconds between each measurement. The measurements take place alternately between the two test sites, the first test site being randomly determined by an independent blinded researcher. The pressure pain threshold in kgf per muscle (test site) is determined by the mean of the 2nd and 3rd measurement.
1 day
Secondary Outcomes (24)
Energy-balance related behavior (child)
1 day
Waist circumference (child)
1 day
Body length (child)
1 day
Body weight (child)
1 day
Body weight (only healthy controls) (child)
1 day
- +19 more secondary outcomes
Other Outcomes (2)
Pain catastrophizing (child)
1 day
Pain catastrophizing (parent)
1 day
Study Arms (2)
Childhood cancer
Children with an established cancer diagnosis (any type) between 8-18 years old that are currently being treated for cancer (not necessarily hospitalized) in the University Hospital Brussels or Ghent.
Healthy controls
Healthy children between 8-12 years old, selected based on age and sex.
Eligibility Criteria
Cancer patients will be recruited by the oncology department of the children's hospital of the University Hospital Brussels and Ghent. All eligibel children between 8-18y and their parents will be informed about the study and receive a consent form. Healthy controls will be recruited from several schools in the neighborhood and from family and acquaintances of the hospital personnel and researchers. In order to be able to compare their outcomes with the intervention group, they will be selected based on age and sex.
You may qualify if:
- All participants:
- Willing to participate and comply with pre-determined interventions
- y (children)
- Child and parent(s)/guardian cohabited for the past 5 years or, in case of divided custody, for at least half of the child's lifetime
- Cancer patients
- Established cancer diagnosis (any type)
- First cancer diagnosis
- Currently being treated for cancer (not necessarily hospitalized) in the University Hospital Brussels or Ghent
You may not qualify if:
- Developmental disabilities (e.g.: autism spectrum disorder, Attention Deficit (Hyperactivity) Disorder)
- Psychiatric disorders (e.g.: anxiety disorder, personality disorder)
- Significant vision or hearing impairment
- Chronic pain diagnosis (e.g.: fibromyalgia, migraine, chronic abdominal pain, etc.)
- Not able to read and speak fluent Dutch (parent and child)
- Already having undergone any kind of self-regulation and/or behavioral therapy for pain (i.e. relaxation, hypnosis, biofeedback, pain neuroscience education, cognitive behavioral therapy, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Universitair Ziekenhuis Brusselcollaborator
- University Ghentcollaborator
Study Sites (1)
University Hospital Brussels
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
June 19, 2019
First Posted
July 2, 2019
Study Start
August 14, 2019
Primary Completion
June 14, 2022
Study Completion
June 14, 2022
Last Updated
June 15, 2022
Record last verified: 2022-06